Name | Number of supported studies | Average coverage | |
---|---|---|---|
kidney distal convoluted tubule epithelial cell | 4 studies | 48% ± 16% | |
epithelial cell of proximal tubule | 3 studies | 20% ± 3% |
Insufficient scRNA-seq data for expression of KL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 4212.02 | 89 / 89 | 89% | 58.39 | 805 / 901 |
prostate | 100% | 814.45 | 244 / 245 | 82% | 20.78 | 412 / 502 |
thymus | 99% | 336.28 | 647 / 653 | 77% | 5.02 | 463 / 605 |
lung | 100% | 887.20 | 576 / 578 | 22% | 1.16 | 250 / 1155 |
breast | 100% | 683.19 | 459 / 459 | 20% | 0.84 | 221 / 1118 |
stomach | 99% | 380.94 | 354 / 359 | 17% | 0.88 | 49 / 286 |
bladder | 100% | 331.33 | 21 / 21 | 15% | 1.69 | 76 / 504 |
intestine | 97% | 401.49 | 941 / 966 | 10% | 0.83 | 52 / 527 |
uterus | 96% | 237.69 | 164 / 170 | 9% | 0.67 | 43 / 459 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.21 | 1 / 1 |
adipose | 100% | 805.95 | 1203 / 1204 | 0% | 0 | 0 / 0 |
spleen | 99% | 281.27 | 238 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 32% | 56.26 | 83 / 258 | 64% | 19.76 | 147 / 230 |
esophagus | 78% | 235.70 | 1126 / 1445 | 12% | 0.56 | 22 / 183 |
pancreas | 48% | 56.04 | 156 / 328 | 34% | 5.23 | 61 / 178 |
heart | 81% | 124.18 | 695 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 68% | 126.56 | 907 / 1335 | 0% | 0 | 0 / 0 |
brain | 60% | 195.67 | 1572 / 2642 | 4% | 0.31 | 31 / 705 |
muscle | 61% | 81.14 | 488 / 803 | 0% | 0 | 0 / 0 |
skin | 53% | 83.76 | 966 / 1809 | 5% | 0.26 | 22 / 472 |
peripheral blood | 38% | 101.10 | 350 / 929 | 0% | 0 | 0 / 0 |
ovary | 19% | 26.72 | 35 / 180 | 1% | 0.08 | 6 / 430 |
tonsil | 0% | 0 | 0 / 0 | 20% | 1.21 | 9 / 45 |
liver | 4% | 4.79 | 10 / 226 | 3% | 0.14 | 14 / 406 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.15 | 2 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0055074 | Biological process | calcium ion homeostasis |
GO_0042421 | Biological process | norepinephrine biosynthetic process |
GO_0008340 | Biological process | determination of adult lifespan |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0014823 | Biological process | response to activity |
GO_0003085 | Biological process | negative regulation of systemic arterial blood pressure |
GO_0090080 | Biological process | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway |
GO_0030501 | Biological process | positive regulation of bone mineralization |
GO_0006112 | Biological process | energy reserve metabolic process |
GO_0033280 | Biological process | response to vitamin D |
GO_1990776 | Biological process | response to angiotensin |
GO_0008543 | Biological process | fibroblast growth factor receptor signaling pathway |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0008422 | Molecular function | beta-glucosidase activity |
GO_0005179 | Molecular function | hormone activity |
GO_0004566 | Molecular function | beta-glucuronidase activity |
GO_0005499 | Molecular function | vitamin D binding |
GO_0005104 | Molecular function | fibroblast growth factor receptor binding |
GO_0017134 | Molecular function | fibroblast growth factor binding |
Gene name | KL |
Protein name | Klotho (EC 3.2.1.31) [Cleaved into: Klotho peptide] |
Synonyms | |
Description | FUNCTION: May have weak glycosidase activity towards glucuronylated steroids. However, it lacks essential active site Glu residues at positions 239 and 872, suggesting it may be inactive as a glycosidase in vivo. May be involved in the regulation of calcium and phosphorus homeostasis by inhibiting the synthesis of active vitamin D (By similarity). Essential factor for the specific interaction between FGF23 and FGFR1 (By similarity). .; FUNCTION: The Klotho peptide generated by cleavage of the membrane-bound isoform may be an anti-aging circulating hormone which would extend life span by inhibiting insulin/IGF1 signaling. . |
Accessions | Q9UEF7 ENST00000380099.4 [Q9UEF7-1] |